Top Markets
Coin of the day
TaiwanJ Pharmaceuticals Co., Ltd. TaiwanJ Pharmaceuticals Co., Ltd.

TaiwanJ Pharmaceuticals Co., Ltd.

6549
Classifica tra le azioni #30194
TaiwanJ Pharmaceuticals Co., Ltd. operates as a specialized biotech firm... TaiwanJ Pharmaceuticals Co., Ltd. operates as a specialized biotech firm dedicated to the research, development, and commercialization of small molecule therapeutics. Initially, its focus within Taiwan has been on tackling chronic organ inflammation stemming from metabolic, autoimmune, or infectious causes. The company's growing pipeline also features specific compounds like JKB-122 and JKB-121, alongside a collection of innovative chemical entities. These new drugs are being developed to address persistent liver conditions and allergic respiratory ailments, such as asthma. TaiwanJ's comprehensive product portfolio is engineered to combat a wide array of diseases, encompassing hepatic inflammation and fibrosis, non-alcoholic steatohepatitis (NASH), non-alcoholic fatty liver disease (NAFLD), various autoimmune disorders, asthma, and atopic dermatitis (eczema). Established in 2011, the company's operations are headquartered in Zhubei, Taiwan.
Prezzo delle azioni
$0.21877731
Capitalizzazione di mercato
$17.53M
Variazione (1 giorno)
-1.57%
Variazione (1 anno)
-16.15%
Paese
TW
Scambia TaiwanJ Pharmaceuticals Co., Ltd. (6549)

Categoria

Storico del rendimento da dividendi per TaiwanJ Pharmaceuticals Co., Ltd. (6549)
Il rendimento da dividendi (TTM) di TaiwanJ Pharmaceuticals Co., Ltd. (simbolo azionario: 6549) al 2026 è: 0
Rendimento medio negli ultimi 5 anni: 0.00%
Storico del rendimento da dividendi per TaiwanJ Pharmaceuticals Co., Ltd. (6549) da 2026 a 2026
Rendimento da dividendi alla fine di ogni anno (TTM)
Anno Rendimento da dividendi Cambia
Non abbastanza dati per le date fornite.
Rendimenti da dividendi (TTM) di aziende simili o concorrenti
Azienda Rendimento da dividendi Il paese
0.00%
US
0.00%
NL
3.12%
AU
0.00%
CH
0.00%
KR